Follow
Atish Patel
Atish Patel
National Cancer Institute, Center for Cancer Research
Verified email at nih.gov
Title
Cited by
Cited by
Year
Silver nanoparticles: synthesis, properties, and therapeutic applications
L Wei, J Lu, H Xu, A Patel, ZS Chen, G Chen
Drug discovery today 20 (5), 595-601, 2015
9892015
Multidrug resistance associated proteins in multidrug resistance
K Sodani, A Patel, RJ Kathawala, ZS Chen
Chinese journal of cancer 31 (2), 58, 2012
3192012
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo …
DL Bhatt, PG Steg, SR Mehta, LA Leiter, T Simon, K Fox, C Held, ...
The Lancet 394 (10204), 1169-1180, 2019
2022019
Role of ABC transporters in cancer chemotherapy
YL Sun, A Patel, P Kumar, ZS Chen
Chinese journal of cancer 31 (2), 51, 2012
1832012
Nilotinib potentiates anticancer drug sensitivity in murine ABCB1-, ABCG2-, and ABCC10-multidrug resistance xenograft models
AK Tiwari, K Sodani, C Dai, AH Abuznait, S Singh, ZJ Xiao, A Patel, ...
Cancer letters 328 (2), 307-317, 2013
1262013
Tyrosine kinase inhibitors as reversal agents for ABC transporter mediated drug resistance
N Anreddy, P Gupta, RJ Kathawala, A Patel, JND Wurpel, ZS Chen
Molecules 19 (9), 13848-13877, 2014
1162014
Roles of sildenafil in enhancing drug sensitivity in cancer
Z Shi, AK Tiwari, AS Patel, LW Fu, ZS Chen
Cancer research 71 (11), 3735-3738, 2011
722011
In vitro, in vivo and ex vivo characterization of ibrutinib: a potent inhibitor of the efflux function of the transporter MRP1
H Zhang, A Patel, SL Ma, XJ Li, YK Zhang, PQ Yang, RJ Kathawala, ...
British journal of pharmacology 171 (24), 5845-5857, 2014
652014
Motesanib (AMG706), a potent multikinase inhibitor, antagonizes multidrug resistance by inhibiting the efflux activity of the ABCB1
YJ Wang, RJ Kathawala, YK Zhang, A Patel, P Kumar, S Shukla, KL Fung, ...
Biochemical pharmacology 90 (4), 367-378, 2014
612014
GW583340 and GW2974, human EGFR and HER-2 inhibitors, reverse ABCG2-and ABCB1-mediated drug resistance
K Sodani, AK Tiwari, S Singh, A Patel, ZJ Xiao, JJ Chen, YL Sun, ...
Biochemical pharmacology 83 (12), 1613-1622, 2012
612012
Telatinib reverses chemotherapeutic multidrug resistance mediated by ABCG2 efflux transporter in vitro and in vivo
K Sodani, A Patel, N Anreddy, S Singh, DH Yang, RJ Kathawala, P Kumar, ...
Biochemical pharmacology 89 (1), 52-61, 2014
582014
PD173074, a selective FGFR inhibitor, reverses ABCB1-mediated drug resistance in cancer cells
A Patel, AK Tiwari, EE Chufan, K Sodani, N Anreddy, S Singh, ...
Cancer chemotherapy and pharmacology 72, 189-199, 2013
582013
Icotinib antagonizes ABCG2-mediated multidrug resistance, but not the pemetrexed resistance mediated by thymidylate synthase and ABCG2
DS Wang, A Patel, S Shukla, YK Zhang, YJ Wang, RJ Kathawala, ...
Oncotarget 5 (12), 4529, 2014
462014
Reversal of MRP7 (ABCC10)-mediated multidrug resistance by tariquidar
YL Sun, JJ Chen, P Kumar, K Chen, K Sodani, A Patel, YL Chen, ...
PloS one 8 (2), e55576, 2013
462013
(2010)
A Patel, N Badhoniya, S Khadse, U Senarath, KE Agho, MJ Dibley, ...
Infant and young child feeding indicators and determinants of poor feeding …, 2005
452005
Masitinib antagonizes ATP-binding cassette subfamily C member 10–mediated Paclitaxel resistance: a preclinical study
RJ Kathawala, K Sodani, K Chen, A Patel, AH Abuznait, N Anreddy, ...
Molecular cancer therapeutics 13 (3), 714-723, 2014
442014
Data modeling techniques for data warehouse
A Patel, J Patel
International Journal of Multidisciplinary Research 2 (2), 240-246, 2012
412012
The BTK inhibitor ibrutinib (PCI-32765) overcomes paclitaxel resistance in ABCB1-and ABCC10-overexpressing cells and tumors
H Zhang, A Patel, YJ Wang, YK Zhang, RJ Kathawala, LH Qiu, BA Patel, ...
Molecular cancer therapeutics 16 (6), 1021-1030, 2017
382017
AST1306, a potent EGFR inhibitor, antagonizes ATP-binding cassette subfamily G member 2-mediated multidrug resistance
H Zhang, YJ Wang, YK Zhang, DS Wang, RJ Kathawala, A Patel, ...
Cancer letters 350 (1-2), 61-68, 2014
382014
Linsitinib (OSI-906) antagonizes ATP-binding cassette subfamily G member 2 and subfamily C member 10-mediated drug resistance
H Zhang, RJ Kathawala, YJ Wang, YK Zhang, A Patel, S Shukla, ...
The international journal of biochemistry & cell biology 51, 111-119, 2014
362014
The system can't perform the operation now. Try again later.
Articles 1–20